Work

MA05.04 Role of QoL in Treatment Decisions for Patients with ALK+ NSCLC

Year: 2023

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.144

Authors: H. Law, J.C. King, H.M. Lin, E. Curran, J. Wiens, L. Cruz, J. Blender, E.S. Venanzi, E. Schenk, J.J. Lin

Institutions: Go2 for Lung Cancer, Takeda (United States), University of Colorado Anschutz, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388044937

Cites:

Cited by:

Related to: 10